Am. J. Respir. Crit. Care Med., Volume 164, Number 2, July 2001, 219-224

"Natural History" of Pulmonary Hypertension in a Series of 131 Patients with Chronic Obstructive Lung Disease

ROMAIN KESSLER, MICHÈLE FALLER, EMMANUEL WEITZENBLUM, ARI CHAOUAT, ATTILA AYKUT, ALAIN DUCOLONÉ, MAY EHRHART, and MONIQUE OSWALD-MAMMOSSER

Service de Pneumologie, Hôpitaux Universitaires, Strasbourg, France

The prognostic value and the evolution of pulmonary hypertension (PH) in patients with markedly hypoxemic chronic obstructive pulmonary disease (COPD), treated or not with long-term oxygen therapy (LTOT), has been extensively investigated. However, little is known in patients with mildly or moderately hypoxemic COPD not requiring LTOT. Therefore, we assessed the evolution of pulmonary hemodynamics in 131 patients with stable COPD by performing two right heart catheterizations at a mean (± SD) time interval of 6.8 ± 2.9 yr. At inclusion (T0), no patient had PH (i.e., the mean pulmonary artery pressure [Ppa] at rest was < 20 mm Hg). Group 1 included 55 patients without exercising PH and group 2 included 76 patients with exercising PH, defined by a pulmonary arterial pressure (Ppa) > 30 mm Hg during a steady-state 40-W exercise. Group 2 patients compared with group 1 patients had a significantly higher resting Ppa (16 ± 3 mm Hg versus 14 ± 2 mm Hg, p = 0.001). At the second catheterization, 33 (25%) patients (9 of 55 in group 1, 24 of 76 in group 2, p = 0.048) showed a resting Ppa > 20 mm Hg, but PH was generally mild, ranging from 20 to 42.5 mm Hg. The mean Ppa at second evaluation was 16 ± 5 mm Hg in group 1 and 19 ± 7 mm Hg in group 2 (p = 0.01). The patients who developed resting PH at the second catheterization (T1) had higher resting and exercising Ppa (p = 0.001 and p = 0.002, respectively), and significantly lower resting and exercising Pa_O2 (p = 0.005 and p = 0.012, respectively) at T0. Logistic regression analysis showed that resting and exercising Ppa were independent predictors (at T0) for the subsequent development of PH (p = 0.029 and p = 0.027, respectively). The patients who developed resting PH (T1) had a significantly worsening of Pa_O2 (from 63.5 mm Hg at T0 to 60 mm Hg at T1, p = 0.047), whereas the Pa_O2 as a mean was stable in the remainder (69.5 mm Hg at T0 and T1). These results show the following. The progression of Ppa over time in patients with COPD with mild to moderate hypoxemia is rather slow, the average change for the group as a whole being of + 0.4 mm Hg/yr. Only about 25% of patients with COPD with mild to moderate hypoxemia and without resting PH at the onset will develop PH during a 6-yr follow-up. The patients with exercising PH at the onset have a significantly increased risk of developing PH over time. Only resting and exercising Ppa at the onset are independently related to the subsequent development of PH. However, in individual cases, the models of linear or logistic regression do not allow a pertinent prediction of the level of Ppa or the presence of PH at the second right heart catheterization.

This article has been cited by other articles:

				J. A. Falk, S. Kadiev, G. J. Criner, S. M. Scharf, O. A. Minai, and P. Diaz Cardiac Disease in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 543 - 548. [Abstract] [Full Text] [PDF]

				M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez Pulmonary Diseases and the Heart Circulation, December 18, 2007; 116(25): 2992 - 3005. [Abstract] [Full Text] [PDF]

				M. R. Fisher, G. J. Criner, A. P. Fishman, P. M. Hassoun, O. A. Minai, S. M. Scharf, a. H. E. Fessler, and for the National Emphysema Treatment Trial (NETT) Estimating pulmonary artery pressures by echocardiography in patients with emphysema Eur. Respir. J., November 1, 2007; 30(5): 914 - 921. [Abstract] [Full Text] [PDF]

				O. Pak, A. Aldashev, D. Welsh, and A. Peacock The effects of hypoxia on the cells of the pulmonary vasculature Eur. Respir. J., August 1, 2007; 30(2): 364 - 372. [Abstract] [Full Text] [PDF]

				C. Nadziejko, K. Fang, A. Bravo, and T. Gordon Susceptibility to pulmonary hypertension in inbred strains of mice exposed to cigarette smoke J Appl Physiol, May 1, 2007; 102(5): 1780 - 1785. [Abstract] [Full Text] [PDF]

				J. L. Wright, H. Tai, R. Wang, X. Wang, and A. Churg Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-{alpha} signaling Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L125 - L133. [Abstract] [Full Text] [PDF]

				H. A. Ghofrani, R. Voswinckel, F. Reichenberger, N. Weissmann, R. T. Schermuly, W. Seeger, and F. Grimminger Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies Cardiovasc Res, October 1, 2006; 72(1): 30 - 40. [Abstract] [Full Text] [PDF]

				J. L. Wright, H. Tai, and A. Churg Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig J Appl Physiol, February 1, 2006; 100(2): 672 - 678. [Abstract] [Full Text] [PDF]

				V. Cottin, H. Nunes, P-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblond, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J-F. Cordier, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur. Respir. J., October 1, 2005; 26(4): 586 - 593. [Abstract] [Full Text] [PDF]

				J L Wright, R D Levy, and A Churg Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment Thorax, July 1, 2005; 60(7): 605 - 609. [Abstract] [Full Text] [PDF]

				P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]

				V. Jounieaux, D. Rose, and P. Aubry Relationships between exercise-induced pulmonary hypertension and nocturnal desaturation Eur. Respir. J., June 1, 2005; 25(6): 1126 - 1127. [Full Text] [PDF]

				G. Thabut, G. Dauriat, J. B. Stern, D. Logeart, A. Levy, R. Marrash-Chahla, and H. Mal Pulmonary Hemodynamics in Advanced COPD Candidates for Lung Volume Reduction Surgery or Lung Transplantation Chest, May 1, 2005; 127(5): 1531 - 1536. [Abstract] [Full Text] [PDF]

				T. Higenbottam Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease: A Case for Treatment Proceedings of the ATS, April 1, 2005; 2(1): 12 - 19. [Abstract] [Full Text] [PDF]

				R. Naeije Pulmonary Hypertension and Right Heart Failure in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 20 - 22. [Abstract] [Full Text] [PDF]

				J. L. Wright, H. Tai, and A. Churg Cigarette Smoke Induces Persisting Increases of Vasoactive Mediators in Pulmonary Arteries Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 501 - 509. [Abstract] [Full Text] [PDF]

				C.C. Christensen, M.S. Ryg, A. Edvardsen, and O.H. Skjonsberg Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients Eur. Respir. J., October 1, 2004; 24(4): 580 - 586. [Abstract] [Full Text] [PDF]

				S. Eddahibi, A. Chaouat, N. Morrell, E. Fadel, C. Fuhrman, A.-S. Bugnet, P. Dartevelle, B. Housset, M. Hamon, E. Weitzenblum, et al. Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Circulation, October 14, 2003; 108(15): 1839 - 1844. [Abstract] [Full Text] [PDF]

				J.L. Wright, S.G. Farmer, and A. Churg A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels Eur. Respir. J., July 1, 2003; 22(1): 77 - 81. [Abstract] [Full Text] [PDF]

				J.A. Barbera, V.I. Peinado, and S. Santos Pulmonary hypertension in chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2003; 21(5): 892 - 905. [Abstract] [Full Text] [PDF]

				S. Santos, V. I. Peinado, J. Ramirez, J. Morales-Blanhir, R. Bastos, J. Roca, R. Rodriguez-Roisin, and J. A. Barbera Enhanced Expression of Vascular Endothelial Growth Factor in Pulmonary Arteries of Smokers and Patients with Moderate Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1250 - 1256. [Abstract] [Full Text] [PDF]

				W MacNee and P M A Calverley Chronic obstructive pulmonary disease * 7: Management of COPD Thorax, March 1, 2003; 58(3): 261 - 265. [Abstract] [Full Text] [PDF]

				D. Chemla, V. Castelain, P. Herve, Y. Lecarpentier, and S. Brimioulle Haemodynamic evaluation of pulmonary hypertension Eur. Respir. J., November 1, 2002; 20(5): 1314 - 1331. [Abstract] [Full Text] [PDF]

				S. M. Scharf, M. Iqbal, C. Keller, G. Criner, S. Lee, and H. E. Fessler Hemodynamic Characterization of Patients with Severe Emphysema Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 314 - 322. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]